Scarica l'app Stockscreener
0.90
11.11%
0.09
Dopo l'orario di chiusura:
.89
-0.01
-1.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Applied Dna Sciences Inc Borsa (APDN) Ultime notizie
Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com South Africa
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus
Applied DNA secures U.S. supply chain for key materials - Investing.com
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | APDN Stock News - GuruFocus
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - standard-journal.com
Press Release Distribution & PR Platform - ACCESS Newswire
US Biotech Leader LineaRx Transforms DNA Manufacturing with Major Domestic Supply Chain Shift - Stock Titan
APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada
Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener
Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa
Applied DNA regains Nasdaq compliance with bid price - Investing.com
Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa
Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com India
Applied DNA sets May 22 for virtual shareholder meeting - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga
Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia
Applied DNA refines pharmacogenomics strategy - Investing.com
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire
Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan
APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada
Applied DNA seeks NY approval for bird flu test By Investing.com - Investing.com South Africa
Applied DNA Seeks New York Approval for H5 Bird Flu Test - MarketScreener
Applied DNA Sciences submits request to NYSDOH for H5 bird flu LDT approval - TipRanks
Applied DNA seeks NY approval for bird flu test - Investing.com Australia
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test - ACCESS Newswire
New H5 Bird Flu Test Advances: Applied DNA's Dual-Detection System Nears Market Launch - Stock Titan
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27 - Business Wire
Just Style - Just Style
APDN Stock Plummets: Opportunity or Warning? - timothysykes.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 - Galveston County Daily News
Applied DNA announces 1-for-50 reverse stock split - MSN
APDN stock plunges to 52-week low of $0.09 amid market challenges - Investing.com
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Sciences to Implement 1-for-50 Reverse Stock Split; Shares Fall -March 12, 2025 at 11:14 am EDT - Marketscreener.com
Applied DNA announces 1-for-50 reverse stock split By Investing.com - Investing.com Australia
Applied DNA Sciences Says 1-For-50 Reverse Stock Split Of Issued And Outstanding Common Stock Effective March 14 - Marketscreener.com
APDN stock plunges to 52-week low of $0.09 amid market challenges By Investing.com - Investing.com South Africa
6.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):